Suppr超能文献

相似文献

1
Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria.
Free Radic Biol Med. 2007 Apr 15;42(8):1193-200. doi: 10.1016/j.freeradbiomed.2007.01.019. Epub 2007 Jan 13.
2
Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Redox Biol. 2014 Jan 9;2:400-10. doi: 10.1016/j.redox.2013.12.017. eCollection 2014.
5
Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
Free Radic Biol Med. 2013 May;58:73-80. doi: 10.1016/j.freeradbiomed.2013.01.006. Epub 2013 Jan 15.
7
New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme.
Dalton Trans. 2006 Jan 28(4):617-24. doi: 10.1039/b513761f. Epub 2005 Dec 19.
9
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
Free Radic Biol Med. 2011 Sep 1;51(5):1035-53. doi: 10.1016/j.freeradbiomed.2011.04.046. Epub 2011 May 6.
10
Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection.
Free Radic Biol Med. 2008 Mar 15;44(6):982-9. doi: 10.1016/j.freeradbiomed.2007.10.058. Epub 2007 Nov 21.

引用本文的文献

1
MnSOD Mimetics in Therapy: Exploring Their Role in Combating Oxidative Stress-Related Diseases.
Antioxidants (Basel). 2024 Nov 23;13(12):1444. doi: 10.3390/antiox13121444.
2
[Research progress of metalloporphyrin against neurodegene-rative diseases].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Jan 25;54(1):81-89. doi: 10.3724/zdxbyxb-2024-0208.
3
Superoxide dismutase and neurological disorders.
IBRO Neurosci Rep. 2024 Jan 23;16:373-394. doi: 10.1016/j.ibneur.2023.11.007. eCollection 2024 Jun.
4
Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia.
Cancer Drug Resist. 2024 Feb 22;7:5. doi: 10.20517/cdr.2023.125. eCollection 2024.
6
The Interplay of Oxidative Stress and ROS Scavenging: Antioxidants as a Therapeutic Potential in Sepsis.
Vaccines (Basel). 2022 Sep 20;10(10):1575. doi: 10.3390/vaccines10101575.
7
HO-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways.
Oxid Med Cell Longev. 2021 Mar 15;2021:6653790. doi: 10.1155/2021/6653790. eCollection 2021.
9
Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.
Antioxid Redox Signal. 2018 Dec 1;29(16):1691-1724. doi: 10.1089/ars.2017.7453. Epub 2018 Aug 28.
10
Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine.
Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):5839-5848. doi: 10.1073/pnas.1804932115. Epub 2018 May 25.

本文引用的文献

1
Kinetic properties of Cu,Zn-superoxide dismutase as a function of metal content--order restored.
Free Radic Biol Med. 2006 Sep 15;41(6):937-41. doi: 10.1016/j.freeradbiomed.2006.05.026. Epub 2006 Jun 3.
3
Reduction of manganese porphyrins by flavoenzymes and submitochondrial particles: a catalytic cycle for the reduction of peroxynitrite.
Free Radic Biol Med. 2006 Aug 1;41(3):503-12. doi: 10.1016/j.freeradbiomed.2006.04.028. Epub 2006 May 11.
4
New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme.
Dalton Trans. 2006 Jan 28(4):617-24. doi: 10.1039/b513761f. Epub 2005 Dec 19.
5
A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):545-52. doi: 10.1016/j.ijrobp.2005.05.026.
7
Kinetics properties of Cu,Zn-superoxide dismutase as a function of metal content.
Arch Biochem Biophys. 2005 Jul 15;439(2):234-40. doi: 10.1016/j.abb.2005.05.016.
10
A mechanism-based antioxidant approach for the reduction of skin carcinogenesis.
Cancer Res. 2005 Feb 15;65(4):1401-5. doi: 10.1158/0008-5472.CAN-04-3334.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验